Abbott Laboratories’ (NYSE: ABT) Navitor transcatheter aortic valve implantation (TAVI) system has received a CE mark, making it available in Europe to those…
Abbott’s Navitor Aortic Heart Valve Replacement Scores European Approval
2021-05-17T20:58:51-04:00May 17th, 2021|
Related Posts
-
easyJet reveals AI use at new control centre in Luton
May 22nd, 2024